Moreover, observations of PSA levels after local treatments such as RP or radiation therapy (RT) have reported that PSA doubling time and time to PSA nadir were significantly associated with prostate cancer-specific survival (PCSS)9–11. The gene discussed is KLK3; the disease is Familial prostate cancer.